Improved
6112 HealthChanged
3786 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
Dr. Templeton describes a malignant fibrous histiocytoma and announces its new name.
Dr. Templeton:
Malignant fibrous histiocytoma has a new name according to our pathology colleagues here. The doctors that look at these cancers under the microscope, they now called it pleomorphic sarcoma. Regardless, it still is the same type of cancer. It is a sarcoma, which means that it’s a cancer outside of the organs.
It most commonly shows up in the soft tissue or in the muscle. Occasionally, you will see it in the fatty tissue; very rare occasion you will see it inside of bone. So it’s usually seen in the soft tissue in muscle. It’s the most common type of soft tissue sarcoma that is diagnosed in the United States. Given that, though, soft tissue sarcomas in general in the United States are very rare. So it’s the most common of a very rare thing.
About Dr. Kim Templeton, M.D.:
Kim Templeton, M.D., received her degree from the University of Missouri School of Medicine with a specialty in orthopedics and musculoskeletal oncology and began her career with an orthopedic residency at Chicago's Rush-Presbyterian-St. Luke's Medical Center.
She then accepted a Musculoskeletal Oncology Fellowship at Massachusetts General Hospital in Boston. In 1995, she came to the KU School of Medicine, where her commitment to excellence and orthopedic education has opened the way to positions of leadership. She is now the Director of the Orthopedic Residency Education Program at the University of Kansas School of Medicine, holds the first Joy McCann Professorship for Women in Medicine and Science, and currently serves as president of the KU Medical Center's Women in Medicine and Science program.
Visit Dr. Templeton at The University of Kansas Hospital